SEER
Seer, Inc.
Biotechnology
Market Cap$105M
5Y Perf.-96.6%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SEER vs TMO
Revenue, margins, valuation, and 5-year total return — side by side.
TMO
Thermo Fisher Scientific Inc.
Medical - Diagnostics & Research
Market Cap$175.76B
5Y Perf.+1.5%
SEER vs TMO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SEER | TMO |
|---|---|---|
| Industry | Biotechnology | Medical - Diagnostics & Research |
| Market Cap | $105M | $175.76B |
| Revenue (TTM) | $16M | $45.20B |
| Net Income (TTM) | $-79M | $6.86B |
| Gross Margin | 40.7% | 39.4% |
| Operating Margin | -5.2% | 17.8% |
| Forward P/E | — | 19.0x |
| Total Debt | $26M | $40.85B |
| Cash & Equiv. | $41M | $9.86B |
SEER vs TMO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SEER
TMO
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| Seer, Inc. (SEER) | 100 | 3.4 | -96.6% |
| Thermo Fisher Scien… (TMO) | 100 | 101.5 | +1.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SEER vs TMO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: TMO leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Seer, Inc. is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
SEER
Seer, Inc.
The Income Pick
SEER is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.84
- Lower volatility, beta 0.84, Low D/E 7.9%, current ratio 16.53x
- Beta 0.84, current ratio 16.53x
Best for: income & stability and sleep-well-at-night
TMO
Thermo Fisher Scientific Inc.
The Growth Play
TMO carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.9%, EPS growth 7.3%, 3Y rev CAGR -0.3%
- 229.1% 10Y total return vs SEER's -96.7%
- 3.9% revenue growth vs SEER's -8.1%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | TMO | 3.9% revenue growth vs SEER's -8.1% |
| Quality / Margins | TMO | 15.2% margin vs SEER's -486.0% |
| Stability / Safety | SEER | Beta 0.84 vs TMO's 1.10, lower leverage |
| Dividends | TMO | 0.4% yield; 8-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | TMO | +16.6% vs SEER's 0.0% |
| Efficiency (ROA) | TMO | 6.4% ROA vs SEER's -25.7%, ROIC 7.5% vs -21.3% |
SEER vs TMO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2023
FY 2025
SEER vs TMO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLTMOLAGGINGSEER
SEERSeer, Inc.
2leads
TMOThermo Fisher Scienti…
3leads
6 Total Categories
CATEGORYLEADERvs SEERMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
TMO5/6
Valuation MetricsMultiples, price ratios, and targets
SEER2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
TMO5/8
Total Returns1Y, 3Y, 5Y total returns with dividends
TMO5/6
Risk & VolatilityBeta, volatility, and downside exposure
SEER2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
TMO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TMO is the larger business by revenue, generating $45.2B annually — 2768.4x SEER's $16M. TMO is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to SEER's -4.9%.
| Metric | SEERSeer, Inc. | TMOThermo Fisher Sci… |
|---|---|---|
| RevenueTrailing 12 months | $16M | $45.2B |
| EBITDAEarnings before interest/tax | -$76M | $10.5B |
| Net IncomeAfter-tax profit | -$79M | $6.9B |
| Free Cash FlowCash after capex | -$46M | $6.7B |
| Gross MarginGross profit ÷ Revenue | +40.7% | +39.4% |
| Operating MarginEBIT ÷ Revenue | -5.2% | +17.8% |
| Net MarginNet income ÷ Revenue | -4.9% | +15.2% |
| FCF MarginFCF ÷ Revenue | -2.8% | +14.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.5% | +6.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +8.6% | +11.3% |
TMO leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
SEER leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | SEERSeer, Inc. | TMOThermo Fisher Sci… |
|---|---|---|
| Market CapShares × price | $105M | $175.8B |
| Enterprise ValueMkt cap + debt − cash | $91M | $206.8B |
| Trailing P/EPrice ÷ TTM EPS | -1.36x | 26.66x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 19.04x |
| PEG RatioP/E ÷ EPS growth rate | — | 12.62x |
| EV / EBITDAEnterprise value multiple | — | 18.99x |
| Price / SalesMarket cap ÷ Revenue | 7.56x | 3.94x |
| Price / BookPrice ÷ Book value/share | 0.36x | 3.33x |
| Price / FCFMarket cap ÷ FCF | — | 27.93x |
SEER leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
TMO leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
TMO delivers a 13.2% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-29 for SEER. SEER carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to TMO's 0.76x. On the Piotroski fundamental quality scale (0–9), TMO scores 6/9 vs SEER's 4/9, reflecting solid financial health.
| Metric | SEERSeer, Inc. | TMOThermo Fisher Sci… |
|---|---|---|
| ROE (TTM)Return on equity | -29.2% | +13.2% |
| ROA (TTM)Return on assets | -25.7% | +6.4% |
| ROICReturn on invested capital | -21.3% | +7.5% |
| ROCEReturn on capital employed | -25.9% | +9.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.08x | 0.76x |
| Net DebtTotal debt minus cash | -$15M | $31.0B |
| Cash & Equiv.Liquid assets | $41M | $9.9B |
| Total DebtShort + long-term debt | $26M | $40.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 5.89x |
TMO leads this category, winning 5 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
TMO leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TMO five years ago would be worth $10,211 today (with dividends reinvested), compared to $470 for SEER. Over the past 12 months, TMO leads with a +16.6% total return vs SEER's 0.0%. The 3-year compound annual growth rate (CAGR) favors TMO at -4.2% vs SEER's -19.0% — a key indicator of consistent wealth creation.
| Metric | SEERSeer, Inc. | TMOThermo Fisher Sci… |
|---|---|---|
| YTD ReturnYear-to-date | +3.8% | -20.1% |
| 1-Year ReturnPast 12 months | 0.0% | +16.6% |
| 3-Year ReturnCumulative with dividends | -46.9% | -11.9% |
| 5-Year ReturnCumulative with dividends | -95.3% | +2.1% |
| 10-Year ReturnCumulative with dividends | -96.7% | +229.1% |
| CAGR (3Y)Annualised 3-year return | -19.0% | -4.2% |
TMO leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
SEER leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SEER is the less volatile stock with a 0.84 beta — it tends to amplify market swings less than TMO's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEER currently trades 78.4% from its 52-week high vs TMO's 73.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SEERSeer, Inc. | TMOThermo Fisher Sci… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.84x | 1.10x |
| 52-Week HighHighest price in past year | $2.41 | $643.99 |
| 52-Week LowLowest price in past year | $1.65 | $385.46 |
| % of 52W HighCurrent price vs 52-week peak | +78.4% | +73.4% |
| RSI (14)Momentum oscillator 0–100 | 47.3 | 39.8 |
| Avg Volume (50D)Average daily shares traded | 402K | 1.9M |
SEER leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates SEER as "Hold" and TMO as "Buy". TMO is the only dividend payer here at 0.36% yield — a key consideration for income-focused portfolios.
| Metric | SEERSeer, Inc. | TMOThermo Fisher Sci… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | — | $654.67 |
| # AnalystsCovering analysts | 4 | 42 |
| Dividend YieldAnnual dividend ÷ price | — | +0.4% |
| Dividend StreakConsecutive years of raises | — | 8 |
| Dividend / ShareAnnual DPS | — | $1.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +11.2% | +1.7% |
Insufficient data to determine a leader in this category.
Key Takeaway
TMO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEER leads in 2 (Valuation Metrics, Risk & Volatility).
Best OverallThermo Fisher Scientific In… (TMO)Leads 3 of 6 categories
Loading custom metrics...
SEER vs TMO: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SEER or TMO a better buy right now?
For growth investors, Thermo Fisher Scientific Inc.
(TMO) is the stronger pick with 3. 9% revenue growth year-over-year, versus -8. 1% for Seer, Inc. (SEER). Thermo Fisher Scientific Inc. (TMO) offers the better valuation at 26. 7x trailing P/E (19. 0x forward), making it the more compelling value choice. Analysts rate Thermo Fisher Scientific Inc. (TMO) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SEER or TMO?
Over the past 5 years, Thermo Fisher Scientific Inc.
(TMO) delivered a total return of +2. 1%, compared to -95. 3% for Seer, Inc. (SEER). Over 10 years, the gap is even starker: TMO returned +229. 1% versus SEER's -96. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SEER or TMO?
By beta (market sensitivity over 5 years), Seer, Inc.
(SEER) is the lower-risk stock at 0. 84β versus Thermo Fisher Scientific Inc. 's 1. 10β — meaning TMO is approximately 30% more volatile than SEER relative to the S&P 500. On balance sheet safety, Seer, Inc. (SEER) carries a lower debt/equity ratio of 8% versus 76% for Thermo Fisher Scientific Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — SEER or TMO?
By revenue growth (latest reported year), Thermo Fisher Scientific Inc.
(TMO) is pulling ahead at 3. 9% versus -8. 1% for Seer, Inc. (SEER). On earnings-per-share growth, the picture is similar: Thermo Fisher Scientific Inc. grew EPS 7. 3% year-over-year, compared to -3. 0% for Seer, Inc.. Over a 3-year CAGR, SEER leads at 29. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SEER or TMO?
Thermo Fisher Scientific Inc.
(TMO) is the more profitable company, earning 15. 1% net margin versus -620. 9% for Seer, Inc. — meaning it keeps 15. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TMO leads at 18. 2% versus -717. 7% for SEER. At the gross margin level — before operating expenses — SEER leads at 49. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SEER or TMO?
In this comparison, TMO (0.
4% yield) pays a dividend. SEER does not pay a meaningful dividend and should not be held primarily for income.
07Is SEER or TMO better for a retirement portfolio?
For long-horizon retirement investors, Seer, Inc.
(SEER) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 84)). Both have compounded well over 10 years (SEER: -96. 7%, TMO: +229. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SEER and TMO?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(SEER: 4.5% · TMO: 6.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.